tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Sagimet Biosciences Reports Q3 2025 Financial Results
PremiumCompany AnnouncementsSagimet Biosciences Reports Q3 2025 Financial Results
30d ago
Optimistic Buy Rating for Sagimet Biosciences Driven by Promising Clinical Progress and Strong Financial Position
Premium
Ratings
Optimistic Buy Rating for Sagimet Biosciences Driven by Promising Clinical Progress and Strong Financial Position
1M ago
Sagimet Biosciences Reports Q3 Results and Updates
Premium
Company Announcements
Sagimet Biosciences Reports Q3 Results and Updates
1M ago
Sagimet Biosciences Highlights Drug Development Success
PremiumCompany AnnouncementsSagimet Biosciences Highlights Drug Development Success
2M ago
Sagimet Biosciences initiated with a Buy at Clear Street
Premium
The Fly
Sagimet Biosciences initiated with a Buy at Clear Street
2M ago
Sagimet Biosciences to present Phase 2b FASCINATE-2 study results
Premium
The Fly
Sagimet Biosciences to present Phase 2b FASCINATE-2 study results
2M ago
Promising Clinical Developments and Strategic Positioning Make Sagimet Biosciences a Buy
PremiumRatingsPromising Clinical Developments and Strategic Positioning Make Sagimet Biosciences a Buy
4M ago
Promising Growth Potential of Sagimet Biosciences: Buy Rating Justified by Strategic Trials and Strong Financial Position
Premium
Ratings
Promising Growth Potential of Sagimet Biosciences: Buy Rating Justified by Strategic Trials and Strong Financial Position
4M ago
Promising Potential of Sagimet Biosciences’ FASN Inhibitors Drives Buy Rating
Premium
Ratings
Promising Potential of Sagimet Biosciences’ FASN Inhibitors Drives Buy Rating
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100